Literature DB >> 11512098

Arthus reaction to recombinant hepatitis B virus vaccine.

H Froehlich1, R Verma.   

Abstract

A severe, local, inflammatory, late-phase reaction accompanied by skin necrosis occurred after an infant was given an intramuscular injection of recombinant hepatitis B virus vaccine. The clinical course and appearance of the rash were typical of an Arthus reaction. Although not identical to this case, prior reported cases of complement-mediated reactions occurring after hepatitis B virus infection or vaccination provide theoretical support for this diagnosis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11512098     DOI： 10.1086/322585

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  The vaccines-associated Arthus reaction.

Authors:  Baozhen Peng; Mingwei Wei; Feng-Cai Zhu; Jing-Xin Li
Journal:  Hum Vaccin Immunother       Date:  2019-05-03       Impact factor: 3.452

2.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

3.  Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages.

Authors:  Efstathios G Stamatiades; Marie-Eve Tremblay; Mathieu Bohm; Lucile Crozet; Kanchan Bisht; Daniela Kao; Carolina Coelho; Xiying Fan; William T Yewdell; Anne Davidson; Peter S Heeger; Sandra Diebold; Falk Nimmerjahn; Frederic Geissmann
Journal:  Cell       Date:  2016-07-28       Impact factor: 41.582

4.  Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.

Authors:  Chao Wang; Ninghua Huang; Qing-Bin Lu; Steven Black; Xiaofeng Liang; Fuqiang Cui
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.